[go: up one dir, main page]

FR2886150B1 - Forme pharmaceutique orale a base d'au moins un principe actif dont la solubilite varie en fonction des conditions de ph gastrique - Google Patents

Forme pharmaceutique orale a base d'au moins un principe actif dont la solubilite varie en fonction des conditions de ph gastrique

Info

Publication number
FR2886150B1
FR2886150B1 FR0551345A FR0551345A FR2886150B1 FR 2886150 B1 FR2886150 B1 FR 2886150B1 FR 0551345 A FR0551345 A FR 0551345A FR 0551345 A FR0551345 A FR 0551345A FR 2886150 B1 FR2886150 B1 FR 2886150B1
Authority
FR
France
Prior art keywords
gastric
accordance
conditions
active ingredient
oral pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0551345A
Other languages
English (en)
Other versions
FR2886150A1 (fr
Inventor
Florence Guimberteau
Gerard Soula
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Flamel Technologies SA
Original Assignee
Flamel Technologies SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0551345A priority Critical patent/FR2886150B1/fr
Application filed by Flamel Technologies SA filed Critical Flamel Technologies SA
Priority to CA002608911A priority patent/CA2608911A1/fr
Priority to US11/920,741 priority patent/US20110159088A1/en
Priority to EP06763281A priority patent/EP1893181A1/fr
Priority to JP2008512842A priority patent/JP2009507760A/ja
Priority to CNA2006800271505A priority patent/CN101227895A/zh
Priority to PCT/EP2006/062609 priority patent/WO2006125811A1/fr
Publication of FR2886150A1 publication Critical patent/FR2886150A1/fr
Application granted granted Critical
Publication of FR2886150B1 publication Critical patent/FR2886150B1/fr
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5005—Wall or coating material
    • A61K9/5021—Organic macromolecular compounds
    • A61K9/5026—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Diabetes (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR0551345A 2005-05-24 2005-05-24 Forme pharmaceutique orale a base d'au moins un principe actif dont la solubilite varie en fonction des conditions de ph gastrique Expired - Fee Related FR2886150B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR0551345A FR2886150B1 (fr) 2005-05-24 2005-05-24 Forme pharmaceutique orale a base d'au moins un principe actif dont la solubilite varie en fonction des conditions de ph gastrique
US11/920,741 US20110159088A1 (en) 2005-05-24 2006-05-24 ORAL PHARMACEUTICAL FOR BASED ON AT LEAST ONE ACTIVE PRINCIPLE WHOSE SOLUBILITY VARIES AS A FUNCTION OF THE GASTRIC pH CONDITIONS
EP06763281A EP1893181A1 (fr) 2005-05-24 2006-05-24 Forme pharmaceutique orale a base d'au moins un principe actif dont la solubilite varie en fonction des conditions de ph gastrique
JP2008512842A JP2009507760A (ja) 2005-05-24 2006-05-24 胃内ｐＨ条件に応じて溶解性が異なる少なくとも１つの有効成分をベースとする経口剤形
CA002608911A CA2608911A1 (fr) 2005-05-24 2006-05-24 Forme pharmaceutique orale a base d'au moins un principe actif dont la solubilite varie en fonction des conditions de ph gastrique
CNA2006800271505A CN101227895A (zh) 2005-05-24 2006-05-24 基于至少一种溶解度作为胃pH条件的函数变化的有效成分的口服药物剂型
PCT/EP2006/062609 WO2006125811A1 (fr) 2005-05-24 2006-05-24 Forme pharmaceutique orale a base d'au moins un principe actif dont la solubilite varie en fonction des conditions de ph gastrique

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0551345A FR2886150B1 (fr) 2005-05-24 2005-05-24 Forme pharmaceutique orale a base d'au moins un principe actif dont la solubilite varie en fonction des conditions de ph gastrique

Publications (2)

Publication Number Publication Date
FR2886150A1 FR2886150A1 (fr) 2006-12-01
FR2886150B1 true FR2886150B1 (fr) 2007-08-24

Family

ID=36123323

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0551345A Expired - Fee Related FR2886150B1 (fr) 2005-05-24 2005-05-24 Forme pharmaceutique orale a base d'au moins un principe actif dont la solubilite varie en fonction des conditions de ph gastrique

Country Status (7)

Country Link
US (1) US20110159088A1 (fr)
EP (1) EP1893181A1 (fr)
JP (1) JP2009507760A (fr)
CN (1) CN101227895A (fr)
CA (1) CA2608911A1 (fr)
FR (1) FR2886150B1 (fr)
WO (1) WO2006125811A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8461187B2 (en) 2004-06-16 2013-06-11 Takeda Pharmaceuticals U.S.A., Inc. Multiple PPI dosage form
AR072477A1 (es) * 2008-07-11 2010-09-01 Solvay Pharm Bv Formulacion farmaceutica de eprosartan. uso.
CN102416170B (zh) * 2011-11-07 2013-08-07 重庆申高生化制药有限公司 多酶片的生产工艺
JOP20190219A1 (ar) 2017-05-09 2019-09-22 Cardix Therapeutics LLC تركيبات صيدلانية وطرق لعلاج أمراض القلب والأوعية الدموية

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57197214A (en) * 1981-05-29 1982-12-03 Tanabe Seiyaku Co Ltd Rapid-releasing microcapsule and its preparation
US5026559A (en) * 1989-04-03 1991-06-25 Kinaform Technology, Inc. Sustained-release pharmaceutical preparation
US5431922A (en) * 1991-03-05 1995-07-11 Bristol-Myers Squibb Company Method for administration of buspirone
US5571533A (en) * 1992-02-07 1996-11-05 Recordati, S.A., Chemical And Pharmaceutical Company Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
FR2704146B1 (fr) * 1993-04-19 1995-07-13 Cripdom Microcapsules d'acide acétylsalicylique à libération contrôlée.
FR2725623A1 (fr) * 1994-10-18 1996-04-19 Flamel Tech Sa Microcapsules medicamenteuses et/ou nutritionnelles pour administration per os
ES2236943T3 (es) * 1997-09-19 2005-07-16 Shire Laboratories Inc. Perlas de disolucion solida.
US6303607B1 (en) * 1998-09-10 2001-10-16 Cv Therapeutics, Inc. Method for administering a sustained release ranolanolazine formulation
US6419960B1 (en) * 1998-12-17 2002-07-16 Euro-Celtique S.A. Controlled release formulations having rapid onset and rapid decline of effective plasma drug concentrations
US7374779B2 (en) * 1999-02-26 2008-05-20 Lipocine, Inc. Pharmaceutical formulations and systems for improved absorption and multistage release of active agents
US6309663B1 (en) * 1999-08-17 2001-10-30 Lipocine Inc. Triglyceride-free compositions and methods for enhanced absorption of hydrophilic therapeutic agents
US6248359B1 (en) * 2000-01-05 2001-06-19 Laboratorios Phoenix U.S.A., Inc. Multi-tablet oxybutynin system for treating incontinence
US8101209B2 (en) * 2001-10-09 2012-01-24 Flamel Technologies Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active principles
EP1490029A4 (fr) * 2002-03-22 2006-02-22 Ranbaxy Lab Ltd Systeme d'administration de medicaments a liberation controlee de pravastatine
FR2842735B1 (fr) * 2002-07-26 2006-01-06 Flamel Tech Sa Microcapsules a liberation modifiee de principes actifs peu solubles pour l'administration per os
CA2508722A1 (fr) * 2002-12-11 2004-06-24 Pfizer Products Inc. Liberation controlee d'une substance active dans un milieu a haute teneur en graisse

Also Published As

Publication number Publication date
FR2886150A1 (fr) 2006-12-01
US20110159088A1 (en) 2011-06-30
CA2608911A1 (fr) 2006-11-30
CN101227895A (zh) 2008-07-23
JP2009507760A (ja) 2009-02-26
WO2006125811A1 (fr) 2006-11-30
EP1893181A1 (fr) 2008-03-05

Similar Documents

Publication Publication Date Title
FR2891459B1 (fr) Microparticules a liberation modifiee d'au moins un principe actif et forme galenique orale en comprenant
DE50212546D1 (de) Orale darreichungsformen für propiverin oder seinen pharmazeutisch annehmbaren salzen mit verlängerter wirkstofffreisetzung
NO20033815L (no) Farmasöytiske salter
DZ3420A1 (fr) Combinaison d'herbicides avec des sulfonylurees speciales
FR2881652B1 (fr) Forme pharmaceutique orale microparticulaire anti-mesuage
FR2892937B1 (fr) Forme pharmaceutique orale microparticulaire anti-mesusage
ITMI20021392A0 (it) Forme farmaceutiche per la somministrazione orale di farmaci liquidi a temperatura ambiente dotate di migliore biodisponibilita'
FR2878159B1 (fr) Medicament oral a liberation modifiee d'au moins un principe actif sous forme multimicrocapsulaire
FR2883073B1 (fr) Procede et dispositif d'acquisition d'une forme geometrique.
FR2867995B1 (fr) Dispositif d'usinage par electro-erosion
NO20052907D0 (no) Cycloalkene dicarboxylic acid compounds as anti-inflammatory, immunomodulatory and anti-proliferatory agents.
FR2886150B1 (fr) Forme pharmaceutique orale a base d'au moins un principe actif dont la solubilite varie en fonction des conditions de ph gastrique
EP2053038A4 (fr) Dérivé d'aminoalcool et immunodépresseur le contenant en tant que principe actif
ATE537822T1 (de) Antidepressivum
FR2848851B1 (fr) Procede d'obtention d'un principe actif presentant des capacites apaisantes, principe actif et compositions obtenues
GT200100033A (es) Sistema de administracion oral controlada para la ingestion diaria de ciprofloxacina.
RU2002107079A (ru) Вещество, обладающее седативным действием
DE502004003170D1 (de) Schmelzformulierte, multipartikuläre orale darreichungsform enthaltend clavulansäure
ITRM20030074A0 (it) Formulazioni semisolide a rilascio immediato intese per la somministrazione orale di farmaci.
FR2864473B1 (fr) Systeme actif d'anti-eblouissement.
ATE401864T1 (de) Orale flüssige citalopram enthaltende formulierungen
ITSS20050009A1 (it) Sistema di mobilita' individuale muscolare innovativo (acronimo smimi).
TH99615A (th) อนุพันธ์พรอสทาแกลนดิน
ITMI20030309A1 (it) Adattatore per filatoi ad estremita' aperta.
ES1054316Y (es) "forjado nervado"

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20120131